182 related articles for article (PubMed ID: 20332676)
61. Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma.
Sinakos E; Dedes I; Papalavrentios L; Drevelegas A; Akriviadis E
Scand J Gastroenterol; 2010 Apr; 45(4):511-2. PubMed ID: 20113152
[No Abstract] [Full Text] [Related]
62. Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.
Kudo M; Ueshima K
Oncology; 2010 Jul; 78 Suppl 1():154-66. PubMed ID: 20616599
[TBL] [Abstract][Full Text] [Related]
63. The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy.
Kudo M
J Gastroenterol Hepatol; 2010 Mar; 25(3):439-52. PubMed ID: 20370723
[TBL] [Abstract][Full Text] [Related]
64. Which treatment modality should we choose for advanced hepatocellular carcinoma?
Kim DY
Korean J Hepatol; 2010 Dec; 16(4):353-4. PubMed ID: 21415577
[No Abstract] [Full Text] [Related]
65. Sorafenib in advanced hepatocellular carcinoma.
Spinzi G; Paggi S
N Engl J Med; 2008 Dec; 359(23):2497-8; author reply 2498-9. PubMed ID: 19052134
[No Abstract] [Full Text] [Related]
66. Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?
Kim DY; Han KH
J Gastroenterol Hepatol; 2011 Nov; 26(11):1585-6. PubMed ID: 22011294
[No Abstract] [Full Text] [Related]
67. [Clinical observation of the treatment with combination of transcatheter arterial chemoembolization and sorafenib for hepatocellular carcinoma with lung metastasis].
Duan F; Wang MQ; Liu FY; Wang ZJ; Song P
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):716-8. PubMed ID: 20021873
[TBL] [Abstract][Full Text] [Related]
68. Hepatocellular carcinoma.
Forner A; Llovet JM; Bruix J
Lancet; 2012 Mar; 379(9822):1245-55. PubMed ID: 22353262
[TBL] [Abstract][Full Text] [Related]
69. [Clinical observation of sorafenib monotherapy in Chinese patients with advanced hepatocellular carcinoma].
Xu L; Li P; Lin XJ; Yuan YF; Zhang YQ; Chen MS
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):58-61. PubMed ID: 19538872
[TBL] [Abstract][Full Text] [Related]
70. Computed tomography findings of sorafenib-treated hepatic tumors in patients with advanced hepatocellular carcinoma.
Kim MJ; Choi JI; Lee JS; Park JW
J Gastroenterol Hepatol; 2011 Jul; 26(7):1201-6. PubMed ID: 21371120
[TBL] [Abstract][Full Text] [Related]
71. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
Rimassa L; Santoro A
Expert Rev Anticancer Ther; 2009 Jun; 9(6):739-45. PubMed ID: 19496710
[TBL] [Abstract][Full Text] [Related]
72. [The hepatocellular carcinoma: alternative therapeutical strategies].
Spangenberg HC; Thimme R; Mohr L; Blum HE
Zentralbl Chir; 2007 Aug; 132(4):322-7. PubMed ID: 17724635
[TBL] [Abstract][Full Text] [Related]
73. Sorafenib and radiation therapy for the treatment of advanced hepatocellular carcinoma.
Horgan AM; Dawson LA; Swaminath A; Knox JJ
J Gastrointest Cancer; 2012 Jun; 43(2):344-8. PubMed ID: 20683678
[TBL] [Abstract][Full Text] [Related]
74. Adjuvant therapy after curative treatment for hepatocellular carcinoma.
Kudo M
Oncology; 2011; 81 Suppl 1():50-5. PubMed ID: 22212936
[TBL] [Abstract][Full Text] [Related]
75. Optimized management of advanced hepatocellular carcinoma: four long-lasting responses to sorafenib.
Abbadessa G; Rimassa L; Pressiani T; Carrillo-Infante C; Cucchi E; Santoro A
World J Gastroenterol; 2011 May; 17(19):2450-3. PubMed ID: 21633647
[TBL] [Abstract][Full Text] [Related]
76. [Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma].
Yamashita T; Kaneko S
Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1335-45. PubMed ID: 22863956
[No Abstract] [Full Text] [Related]
77. Molecular targeted therapies in hepatocellular carcinoma.
Llovet JM; Bruix J
Hepatology; 2008 Oct; 48(4):1312-27. PubMed ID: 18821591
[TBL] [Abstract][Full Text] [Related]
78. Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy?
Boschetti G; Walter T; Hervieu V; Cassier P; Lombard-Bohas C; Adham M; Scoazec JY; Dumortier J
Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):1015-8. PubMed ID: 20075738
[TBL] [Abstract][Full Text] [Related]
79. [Advanced hepatocellular carcinoma: importance of clinical trials].
Aedo V; Cristina V; Raymond E; Faivre S
Rev Med Suisse; 2015 May; 11(475):1149-51. PubMed ID: 26152091
[TBL] [Abstract][Full Text] [Related]
80. Sorafenib for advanced-stage hepatocellular carcinoma.
Tomuleasa C; Cristea V; Irimie A
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):346-7. PubMed ID: 22266833
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
